Antifungal and Antibiofilm In Vitro Activities of Ursolic Acid on Cryptococcus neoformans

被引:8
|
作者
Wang, Wen-Jing [1 ]
Liu, Chan-Chan [2 ]
Li, Yan-Tong [1 ]
Li, Miao-Qian [1 ]
Fu, Yu-Ting [1 ]
Li, Xin-Chen [1 ]
Jie-Kang [3 ]
Qian, Wei-Dong [1 ,4 ]
机构
[1] Shaanxi Univ Sci & Technol, Sch Food & Biol Engn, Xian 710021, Peoples R China
[2] Xian Med Coll, Xian 710309, Peoples R China
[3] Shaanxi Inst Prod Qual Supervis & Inspect, Xian 710048, Peoples R China
[4] Shaanxi Univ Sci & Technol, Sch Food & Biol Engn, Dept Pharm, Xian 710021, Peoples R China
关键词
VIRULENCE; CAPSULE; PLANTS;
D O I
10.1007/s00284-022-02992-5
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Ursolic acid (UA) exists in a variety of medicinal plants. UA exhibits antimicrobial activity against several microorganisms; however, little is known regarding the potential antifungal effect of UA on Cryptococcus neoformans (C. neoformans). The antifungal and antibiofilm activities of UA on C. neoformans H99 were evaluated in this study. Minimum inhibitory concentration (MIC) of UA against C. neoformans H99 was determined by microdilution technique, and its action mode was elucidated by clarifying the variations in cell membrane integrity, capsule, and melanin production. Moreover, the inhibition and dispersal effects of UA on biofilm formation and mature biofilms by C. neoformans H99 were evaluated using crystal violet (CV) assay, optical microscopy, field emission scanning electron microscopy and confocal laser scanning microscopy. The results indicated that the MIC value of UA against C. neoformans H99 was 0.25 mg/mL. UA disrupted the cell membrane integrity, inhibited the capsule and melanin production of C. neoformans H99 in a concentration-dependent manner. Further, UA presented the inhibitory effect on biofilm formation and dispersed mature biofilms, as well as compromised the cell membrane integrity of C. neoformans H99 cells within biofilms. Together, these results indicate that UA might be a potential therapeutic option for the treatment of C. neoformans-related infections.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Role of the capsule in microglial cell-Cryptococcus neoformans interaction: impairment of antifungal activity but not of secretory functions
    Barluzzi, R
    Brozzetti, A
    Delfino, D
    Bistoni, F
    Blasi, E
    MEDICAL MYCOLOGY, 1998, 36 (04) : 189 - 197
  • [32] Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation
    Sangalli-Leite, Fernanda
    Scorzoni, Liliana
    Alves de Paula e Silva, Ana Carolina
    da Silva, Julhiany de Fatima
    de Oliveira, Haroldo Cesar
    Singulani, Junya de Lacorte
    Gullo, Fernanda Patricia
    da Silva, Rosangela Moraes
    Regasini, Luis Octavio
    Siqueira da Silva, Dulce Helena
    Bolzani, Vanderlan da Silva
    Fusco-Almeida, Ana Marisa
    Soares Mendes-Giannini, Maria Jose
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 48 (05) : 504 - 511
  • [33] Characterization of the Complete Uric Acid Degradation Pathway in the Fungal Pathogen Cryptococcus neoformans
    Lee, I. Russel
    Yang, Liting
    Sebetso, Gaseene
    Allen, Rebecca
    Doan, Thi H. N.
    Blundell, Ross
    Lui, Edmund Y. L.
    Morrow, Carl A.
    Fraser, James A.
    PLOS ONE, 2013, 8 (05):
  • [34] In Vitro Analysis of Metabolites Secreted during Infection of Lung Epithelial Cells by Cryptococcus neoformans
    Liew, Kah Leong
    Jee, Jap Meng
    Yap, Ivan
    Yong, Phelim Voon Chen
    PLOS ONE, 2016, 11 (04):
  • [35] Uncontrolled transposition following RNAi loss causes hypermutation and antifungal drug resistance in clinical isolates of Cryptococcus neoformans
    Priest, Shelby J.
    Yadav, Vikas
    Roth, Cullen
    Dahlmann, Tim A.
    Kuck, Ulrich
    Magwene, Paul M.
    Heitman, Joseph
    NATURE MICROBIOLOGY, 2022, 7 (08) : 1239 - +
  • [36] Methamphetamine Enhances Cryptococcus neoformans Melanization, Antifungal Resistance, and Pathogenesis in a Murine Model of Drug Administration and Systemic Infection
    Erives, Victor H.
    Munzen, Melissa E.
    Zamith-Miranda, Daniel
    Hernandez, Hazael
    Manepalli, Swetha
    Nguyen, Long N.
    Hamed, Mohamed F.
    Nosanchuk, Joshua D.
    Martinez, Luis R.
    INFECTION AND IMMUNITY, 2022, 90 (04)
  • [37] Structural features of Cryptococcus neoformans bifunctional GAR/AIR synthetase may present novel antifungal drug targets
    Chua, Sheena M. H.
    Wizrah, Maha S., I
    Luo, Zhenyao
    Lim, Bryan Y. J.
    Kappler, Ulrike
    Kobe, Bostjan
    Fraser, James A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 297 (04)
  • [38] Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone®) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection
    Alves, Vinicius
    Martins, Pedro Henrique
    Miranda, Bruna
    de Andrade, Iara Bastos
    Pereira, Luiza
    Maeda, Christina Takiya
    Araujo, Glauber Ribeiro
    Frases, Susana
    JOURNAL OF FUNGI, 2023, 9 (08)
  • [39] Phytochemical Analysis and Antifungal Potentiating Activity of Extracts from Loquat (Eriobotrya japonica) against Cryptococcus neoformans Clinical Isolates
    Bisso, Borel Ndezo
    Kayoka-Kabongo, Prudence Ngalula
    Tchuenguem, Roland Tchuenteu
    Dzoyem, Jean Paul
    ADVANCES IN PHARMACOLOGICAL AND PHARMACEUTICAL SCIENCES, 2022, 2022
  • [40] Antibacterial and Antibiofilm Activities of Chlorogenic Acid Against Yersinia enterocolitica
    Chen, Kun
    Peng, Chuantao
    Chi, Fang
    Yu, Chundi
    Yang, Qingli
    Li, Zhaojie
    FRONTIERS IN MICROBIOLOGY, 2022, 13